Oesophageal cancer gene identified

May 9, 2014, University of Cambridge
Multiple copies of the TRIM44 gene in an oesophageal cancer cell line. Credit: Professor Rebecca Fitzgerald and Dr Johnny Ong

(Medical Xpress)—A newly-discovered gene linked to oesophageal cancer holds the promise of new treatments for this notoriously difficult-to-fight disease.

Researchers believe based on their discovery could help up to 15% of the 8,500 people diagnosed with oesophageal in the UK every year. The study, by scientists from the University of Cambridge, is published in the Journal of the National Cancer Institute.

With the advance of DNA sequencing, researchers are increasingly able to identify genes associated with diseases. Unfortunately, more often than not the function of the gene is unknown, making it difficult to develop a treatment based on the discovery.

The new Cambridge research found not only that the TRIM44 gene plays a key role in the development of but also discovered how the gene drives the disease. The new research reveals that over-expression (when there are multiple copies) of TRIM44 leads to higher activity of the mTOR gene, which regulates cell growth and division - processes that become uncontrolled in cancer.

"We know how effective treatments targeting the over-expression of can be – just look at the success of Herceptin for breast and ," said Professor Rebecca Fitzgerald, lead author of the research from the MRC Cancer Unit at the University of Cambridge. "As there are already a number of drugs which target mTOR, we are hopeful that our discovery could lead to new treatments within the next five years."

The researchers have already found that when they treat tumours in mice which are over-expressing TRIM44 with mTOR inhibitors, they reduced in size. Interestingly, they have also performed the same experiments with cells from human breast cancers, and found the same results, indicating that these findings could also be applied to other cancers.

Professor Fitzgerald added: "For cancer of the oesophagus, and other cancers such as , when the TRIM44 gene is over-expressed, it can also be used to indicate the likely response of an individual to an mTOR inhibitor drug. By tailoring the treatment to the individual, we increase the chance that it will be effective at fighting the disease."

Oesophageal cancer is the ninth commonest cancer in the UK, and the sixth most common cause of cancer death. Many people are unaware of cancer of the oesophagus and symptoms are often ignored. As a result, the disease is frequently at an advanced stage when it is diagnosed. Only around 15% of people diagnosed with oesophageal cancer are alive five years later.

Explore further: Tumour expression of leptin associated with chemotherapy resistance

More information: The paper, "Amplification of triM44: Pairing a Prognostic target With Potential therapeutic Strategy," is available online: jnci.oxfordjournals.org/conten … dju050.full.pdf+html

Related Stories

Tumour expression of leptin associated with chemotherapy resistance

February 26, 2014
Patients with the most common type of oesophageal cancer are less likely to respond to chemotherapy when their tumours are high in a protein called leptin, according to research published in the British Journal of Cancer.

High risk oesophageal cancer gene discovered

January 19, 2012
New research from Queen Mary, University of London has uncovered a gene which plays a key role in the development of oesophageal cancer (cancer of the gullet).

Patients with mouth and oesophageal cancers take longer to seek help from GP

February 11, 2014
People with cancers of the mouth and oesophagus are waiting longer between first noticing a symptom and going to their GPs compared to patients with other types of cancers, according to research published in the International ...

More oesophageal cancer patients benefit from pre-op chemo than previously thought says study

December 23, 2013
More oesophageal cancer patients than previously thought are benefiting from having chemotherapy before an operation to remove their tumour, according to new research published in the World Journal of Gastroenterology.

Genomic testing links 'exceptional' drug response to rare mutations in bladder cancer

March 13, 2014
A patient with advanced bladder cancer in a phase I trial had a complete response for 14 months to a combination of the targeted drugs everolimus and pazopanib, report scientists led by a Dana-Farber Cancer Institute researcher, ...

Deaths from oesophageal cancer up by almost 50 per cent in last 40 years

January 6, 2014
The number of people dying from oesophageal cancer – cancer of the gullet or food pipe – has risen by 49 per cent in the last 40 years according to new figures published by Cancer Research UK, today.

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.